Beta Bionics logo

Beta Bionics

Irvine, CA

Beta Bionics is a biotechnology company that develops an integrated bionic pancreas system called the iLet. The iLet Bionic Pancreas System was granted breakthrough designation in all configurations (insulin-only, glucagon-only, and bihormonal), including use with Zealand Pharmaโ€™s dasiglucagon, a glucagon analogue with a stability profile in a ready-to-use aqueous solution. It also offers a bionic pancreas device for glucose metabolism to the diabetes community.

betabionics.com

Company Details

Founded

2015

Employees

Between 200 - 500 employees

Raised

$353,452,928

Headquarters Location

Irvine, CA

Public

Yes

Acquired

No

CEO

Sean SaintSean Saint

Founders

Toby Milgrome
Sean Saint
Sean Saint
Ed Damiano
Ed Damiano

Company Collections

These are collections Beta Bionics is a part of. Click on the collection name to view similar companies.

Beta Bionics' Tech Stack

Company Collections For Beta Bionics

Beta Bionics Headquarters Location

14150 Myford Rd, Irvine, CA 926061004

Total Amount Raised: $353,452,928

Beta Bionics Funding Rounds

  • IPO

    Unknown

  • Series E

    $60,000,000

    Series E Investors

    Wellington Management
    Omega Fund Management
    Soleus Capital
    Marshall Wace
    Perceptive Advisors
    Sands Capital Management
    RTW Investments
    Eventide
  • Series D

    $100,000,000

    Series D Investors

    Omega Fund Management
    Sands Capital Management
    ArrowMark Colorado Holdings
    Eventide
    RTW Investments
    Soleus Capital
    Farallon Capital Management
    Perceptive Advisors
    Pura Vida Investments
    Marshall Wace
    LifeSci Venture Partners
  • Series C

    $57,000,000

    Series C Investors

    Eventide
    Farallon Capital Management
    Perceptive Advisors
    RTW Investments
    Soleus Capital
    Pura Vida Investments
    Novo Nordisk
    LifeSci Venture Partners
    ArrowMark Colorado Holdings
  • Series B

    $63,000,000

    Series B Investors

    Perceptive Advisors
    Soleus Capital
    Farallon Capital Management
    ArrowMark Colorado Holdings
    RTW Investments
    Eventide
  • Series B

    $63,000,000

    Series B Investors

    Eventide
    RTW Investments
    Dexcom
    Zealand Pharma
    LifeSci Venture Partners
    ArrowMark Colorado Holdings
  • Grant

    $2,000,000

    Grant Investors

    NIDDK
  • Series Unknown

    $2,452,916

  • Equity Crowdfunding

    $1,000,000

  • Series A

    $5,000,000

    Series A Investors

    Eli Lilly and Company
    Novo Nordisk
Funding info provided by Diffbot.

Beta Bionics Reviews

0 out of 5 stars

Based on 0 reviews

Review data

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Beta Bionics.

Recent reviews